This compound is a chiral ester derivative featuring a pyrimidine ether linkage and a diphenylmethane core. It is primarily utilized as an intermediate in the synthesis of small-molecule pharmaceuticals.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1106685-61-3
Ambrisentan
pharmaceutical raw material
(R)-ambrisentan
pharmaceutical raw material
R,S-Ambrisentan-acyl-b-D-glucuronide
pharmaceutical intermediate
8-Amino-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-4-one
pharmaceutical intermediate
1,4-Dioxaspiro[4.5]decane-8-boronic acid pinacol ester
pharmaceutical intermediate
6FDA
pharmaceutical intermediate
AGN-PC-07RIXJ
pharmaceutical raw material
Rac Ambrisentan-d3 Methyl Ester
research compound
methyl (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoate
RCOLWOXJIUGEGI-HXUWFJFHSA-N
CC1=CC(=NC(=N1)O[C@H](C(=O)OC)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C